Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for its Visitag Surpoint External Processing Unit, and enrollment has begun in its post-market approval study.

The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI) scanner from Siemens Healthineers that brings Siemens’ BioMatrix technology to the 1.5T market. This technology addresses patient anatomical and physiological differences, as well as differences in how users set up and conduct MRI exams, to increase productivity and decrease rescans for improved efficiency and patient satisfaction.

Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those most at risk for 30-day readmission, researchers from UT Southwestern found.

The U.S. Food and Drug Administration (FDA) granted market clearance for FibriCheck, a Belgian medical smartphone application for the detection of heart rhythm disorders. The approval makes FibriCheck the first-FDA approved app for heart rhythm disorders by using only an optical signal originating from a non-medical device such as a smartphone.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now